medigraphic.com
ISSN 1561-2945 (Print)

2022, Number 4

<< Back Next >>

Revista Cubana de Cirugía 2022; 61 (4)

Results of using prosthesis in esophageal and cardia cancer

Adefna PRI, Mederos CON, Leal MA, Castellanos GJA, Félix DY

Language: Spanish
References: 21
Page:
PDF size: 435.63 Kb.


ABSTRACT

Introduction: Esophageal and cardia cancer is a serious disease, in which more than three quarters of the treated patients are in advanced stage. In Cuba there is experience with original esophageal prostheses or others domestically built.
Objective: To evaluate the results of the experience of the Comandante Manuel Fajardo and Miguel Enriquez university hospitals with transtumoral prostheses in unresectable esophageal cancer.
Methods: An observational, descriptive, retrospective, case-series type study was carried out with a sample of 197 patients treated with prosthesis for advanced esophageal cancer in the university hospitals Comandante Manuel Fajardo and Miguel Enríquez in the period 1995-2020.
Results: The male sex predominated, while the most affected ages were the sixth and seventh decades. The most frequent tumor location was the lower third of the esophagus and cardia, while squamous cell carcinoma was the most frequent histological type. Rigid prostheses of endotracheal tubes were used in 71 %; Heering prostheses, in 20.8 %; and self-expanding prostheses, in 8.2 %. The most commonly used prostheses at Manuel Fajardo and Miguel Enriquez hospitals were the rigid prosthesis of handmade construction and the Heering prosthesis, respectively. The least used was the self-expanding prosthesis. There was a 10.1 % of complications, with no surgical mortality.
Conclusions: Although self-expanding prostheses are easy to place by endoscopy, it is an expensive method, even being ideal. The industrial or handmade rigid plastic prosthesis can also offer quality of life without dysphagia, avoiding the patient's death with an abdominal ostomy.


REFERENCES

  1. Barrera Ortega JC, Mederos Curbelo ON, Castellanos González JA, Romero Díaz CA, Cruz González P, Cruz Caloca G, et al. Tratamiento paliativo en el cáncer de esófago y cardias. Cir. Gen. 2018 [acceso 14/09/2022];40(1):17-23. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-00992018000100017&lng=es1.

  2. Barreras Ortega JC, Mederos Curbelo ON, Romero Díaz CA, Cantero Ronquillo A, Menchaca Díaz JL, Castellanos González JA, et al. Resultados quirúrgicos en el cáncer de esófago y cardias. Rev. Cubana Onc. 2000 [acceso 12/09/2022];(16):116-9. Disponible en: http://bvs.sld.cu/revistas/onc/vol17_2_00/oncsu201.htm2.

  3. Barreras Ortega JC, Mederos Curbelo ON, Romero Díaz CA, Cantero Ronquillo A, Menchaca Díaz JL, Castellanos González JA, et al. Estrategia en el cáncer de esófago torácico y cardias irresecable. Rev Cubana Cir. 2001 [acceso 14/09/2022];40(2):119-22. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932001000200006&lng=es3. .

  4. Barreras Ortega JC, Mederos Curbelo ON, Romero Díaz CA, Cantero Ronquillo A, Del Campo Abad RJ, Valdés Jiménez J, et al. Cáncer no resecable de esófago y cardias. ¿Prótesis o tubo gástrico? Arch Cir Gen Dig. 2005. [acceso 12/09/ 2022]. Disponible en: http://www.cirugest.com/revista/2005/02/2005-01-24.htm4.

  5. Barrera Ortega JC, Mederos Curbelo ON, Da Costa Fernández JM, Gigato Díaz A. Efectividad del alcohol absoluto para canalizar los tumores irrresecables de esófago. Rev Cubana Cir. 2010 [acceso 14/09/2022];49(4):9-14. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932010000400002&lng=es5. .

  6. Mederos Curbelo ON, Leal Mursulí A, García Gutiérrez A, Barrera Ortega JC, Valdés Jiménez J, Romero Díaz CA, et al. Qué hacen y qué hacemos en el cáncer de esófago y cardias. Rev Cubana Cir. 2005 [acceso 14/09/2022];44(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932005000400010&lng=es6.

  7. Oliva Anaya CA, Mederos Curbelo ON, García Sierra JC, Barrera Ortega JC, Castellanos González JA. Soporte nutricional y calidad de vida en pacientes con cáncer de esófago y cardias. Rev Cubana Cir. 2016 [acceso 14/09/2022];55(2). Disponible en: https://revcirugia.sld.cu/index.php/cir/article/view/4247.

  8. García Gutiérrez A, Delgado García G, González Hernández L. Cirugía del esófago en Cuba: siglos XIX al XXI, Investigación bibliográfica. Rev Cubana Cir. 2004 [acceso 14/09/2022];43(3-4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932004000300009&lng=es8.

  9. Saa Vidal R, Mederos Curbelo ON, Barreras Ortega J, Menchaca Díaz J, Martín Gil LM, Rodríguez PT, et al. Implantación de prótesis transtumorales. Rev Cir Esp. 1996;59(3):94.

  10. Cabrera Hernández P, Morales Díaz I. Uso de la prótesis transtumoral en el cáncer irresecable de esófago: Prótesis de Häring. Rev Cubana Cir. 1987;26(1):115-23.

  11. Adefna Pérez Radamés I, Leal Mursulí A, Ramos Díaz N, Goitizolo Vildosteguí E, Roque González R, Rodríguez Varela R, et al. Resultados del uso de la prótesis transtumoral en el cáncer de esófago avanzado. Rev Cubana Cir. 2000 [acceso 14/09/2022];39(3):213-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932000000300007&lng=es11. .

  12. Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW, et al. Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time. Endoscopy. 2019;51(1):18-29. DOI: https://doi.org/10.1055/a-0644-249512.

  13. Kim KY, Tsauo J, Song HY, Kim PH, Park JH. Self-Expandable Metallic Stent Placement for the Palliation of Esophageal Cancer. J Korean Med Sci. 2017 Jul;32(7):1062-1071. DOI: 10.3346/jkms.2017.32.7.1062. PMID: 28581260; PMCID: PMC5461307.

  14. Paiji C, Sedarat A. Endoscopic Management of Esophageal Cancer. Cancers (Basel). 2022;14(15):3583. DOI: https://doi.org/10.3390/cancers1415358314.

  15. Alonso Lárraga JO, Flores Carmona DY, Hernández Guerrero A, Ramírez Solís ME, de la Mora Levy JG, Sánchez del Monte JC, et al. Prótesis totalmente cubiertas versus parcialmente cubiertas para el tratamiento paliativo del cáncer de esófago: ¿hay alguna diferencia? Rev de Gastroenterología de México. 2018;83:228-33. DOI: https://doi.org/10.1016/j.rgmx.2017.07.00415.

  16. Conio M, Savarese MF, Filiberti RA, Huntley Baron T, Caruso A, Manta R, et al. Palliation of malignant esophageal obstruction using an anti-migration self-expandable metal stent: Results of a prospective multicenter study. Clinics and Research in Hepatology and Gastroenterology. 2021;45. DOI: https://doi.org/10.1016/j.clinre.2021.10168316. .

  17. Ivanov AI, Popov VA, Burmistrov MV. Complications of endoscopic esophageal stent implantation. Kazan medical journal. 2021;102(1):74-84. DOI: https://doi.org/10.17816/KMJ2021-7417.

  18. Chytrosz P, Golda-Cepa M, Wlodarczyk J, Kuzdzal J, El Fray M, Kotarba A. et al. Characterization of Partially Covered Self-Expandable Metallic Stents for Esophageal Cancer Treatment: In Vivo Degradation. ACS Biomaterials Science & Engineering. 2021;7(4):1403-13. DOI: https://doi.org/10.1021/acsbiomaterials.0c0177318.

  19. Conio M, Savarese MF, Filiberti RA, Baron TH, Caruso A, Manta R, et al. Palliation of malignant esophageal obstruction using an anti-migration self-expandable metal stent: Results of a prospective multicenter study. Clin Res Hepatol Gastroenterol. 2021;45(3):101683. DOI: https://doi.org/10.1016/j.clinre.2021.10168319.

  20. Das KK, Hasak S, Elhanafi S, Visrodia KH, Ginsberg GG, Ahmad NA, et al. Performance and Predictors of Migration of Partially and Fully Covered Esophageal Self-Expanding Metal Stents for Malignant Dysphagia. Clin Gastroenterol Hepatol. 2021;19(12):2656-63.e2. DOI: https://doi.org/10.1016/j.cgh.2020.09.01020.

  21. Rodríguez-Pinto E, Pereira P, Baron Todd H., Macedo G. Self-expandable metal stents are a valid option in long-term survivors of advanced esophageal cancer. Rev. Esp. Enferm. Dig. 2018 [acceso 27/09/2022];110(8):500-4. DOI: https://dx.doi.org/10.17235/reed.2018.5323/201721.




2020     |     www.medigraphic.com